Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT00970658
Eligibility Criteria:
Inclusion Criteria:
* Patients of both sexes, of any race, aged 12 years;
* Ability to read, understand and sign the Consent Form, in the case of children under age monitoring and consent of the person responsible;
* Clinical diagnosis of bruises, sprains, trauma, muscle damage occurring in times less than 24 hours or myalgia, pain miofasciais or tendonitis.
* Patients able to understand and maintain the clinical protocol
Exclusion Criteria:
* Known hypersensitivity to components of the formulas of both the product and the comparative test.
* Known hypersensitivity to paracetamol.
* Location of the lesion with skin wound or irritated.
* Hepatic or renal diseases known.
* Pregnant or breastfeeding.
* Patients who require surgery or immobilization rigid;
* Patients with fractures or rupture of the ligaments.
* Patients in use of anticoagulants.
* Patients with severe concomitant systemic diseases such as cancer, diabetes, congenital or acquired heart disease, hematological diseases, convulsive disorders, autoimmune diseases, renal failure, infections, hormonal disorders and pulmonary disorders.
* History of alcoholism or use of illicit drugs;
* Use of non-steroidal anti-inflammatory drugs, corticosteroids or venoterápicos, topics or any other form of administration.
* Conditions which in the opinion of the investigator makes the patient unsuitable to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT00970658
Study Brief:
Protocol Section:
NCT00970658